Atlas Trials

Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas

Clinical trial NCT03670069 · TERMINATED

Trial details

NCT number
NCT03670069
Sponsor
Fred Hutchinson Cancer Center
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic LeiomyosarcomaMetastatic Synovial SarcomaMetastatic Undifferentiated Pleomorphic SarcomaAdvanced Myxoid LiposarcomaAdvanced Soft Tissue SarcomaMetastatic Myxoid LiposarcomaMetastatic Round Cell LiposarcomaMetastatic Soft Tissue SarcomaRefractory LeiomyosarcomaRefractory Myxoid LiposarcomaRefractory Round Cell LiposarcomaRefractory Soft Tissue Sarcoma
Start date
2019-09-30
Primary completion
2023-03-04
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.